{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-007567","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.880688+00:00","generated_at":"2026-05-15T17:22:02.260847+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)","bullets":["Revenue $48.5M (+10.6% YoY); operating loss ($10.6M) vs profit $1.5M last year, driven by $12.2M intangible asset impairment.","GAAP EPS ($0.45) includes ($0.57) impairment charge; adjusted EBITDA $5.7M (11.7% sales) vs $3.9M.","Battery & Energy sales $45.9M (+15.1% YoY); Communications Systems $2.6M (-35.2%).","Backlog $110.2M (+22% from Q3); management expects improved 2026 results.","Rebranding consolidates sub-brands under Ultralife; expects $1.4M tax credit under 45X."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-007567","json":"https://secwatch.observer/filing/0001437749-26-007567.json","markdown":"https://secwatch.observer/filing/0001437749-26-007567.md","text":"https://secwatch.observer/filing/0001437749-26-007567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774926007567/0001437749-26-007567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774926007567/ulbi20260310_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:22:02.260847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}